منابع مشابه
Introducing “Agreement on what to Measure in Randomised Controlled Trials in Burn Care” Research Project
پروژه پژوهشی "توافق دربارهی پیامدهای قابل اندازهگیری در کارآزمایی های کنترلدار مربوط به مراقبتهای سوختگی" توسط گروهی از پژوهشگران با تجربه، در حوزه سوختگی، زیر نظر دکتر Young از کشور انگلستان در حال انجام میباشد. هدف نهایی از انجام این مطالعه، تهیه و تدوین مجموعهای از پیامدهای اساسی (core outcome set (COS)) است که در گزارش کارآزمایی های شاهددار تصادفی مربوط به مراقبتهای سوختگی باید مور...
متن کاملEthical considerations in placebo-controlled randomised clinical trials
SUMMARY Ethical considerations in standard medical care and clinical research are underpinnings to quality medicine. Similarly, the placebo-controlled double-blind randomised clinical trial is the gold standard for medical research and fundamental to the development of evidence-based medicine. Researchers and clinicians are challenged by ethical concerns in the informed consent with a need to m...
متن کاملQuality of randomised controlled trials
Editor—The Save European Science campaign (www.SaveEuropeanResearch.org) was launched on 9 December 2003 out of concern for the future of academic and investigator led research in Europe with the advent of the European Union clinical trials directive (see p 240). It was launched from a cancer platform but is inclusive in spirit and has already gained momentum in cardiology, dermatology, and psy...
متن کاملRandomised controlled trials (RCTs)--essentials.
Correspondence to: Y H Chan Tel: (65) 6317 2121 Fax: (65) 6317 2122 Email: chanyh@ cteru.gov.sg The prospective, randomised, controlled, blinded (if possible), sample-size calculated study with a preplanned statistical analysis and trial monitoring is undoubtedly the gold standard for a therapeutic or interventional clinical study. RCTs carried out recently have discredited some treatments deem...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1991
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.302.6787.1271-c